Results 51 to 60 of about 3,569 (208)

Estimated hazards of composite cardiovascular events (primary outcome), all-cause mortality (secondary outcome), and the combined outcome (primary plus secondary) by the use of alfacalcidol and the baseline dialysate calcium concentration.

, 2022
Estimated hazard was plotted against the dialysate calcium concentration stratified by the use of alfacalcidol.
Masaaki Inaba (172320), Ayumi Shintani (11873), Shinya Nakatani (522972), Katsuhito Mori (522971), Daijiro Kabata (4966756), Tetsuo Shoji (172301), Kunitoshi Iseki (636721), Masanori Emoto (172308), Tomoaki Morioka (522973)   +8 more
core   +1 more source

Association Between Secondary Hyperparathyroidism and Body Composition in Pediatric Patients With Moderate and Advanced Chronic Kidney Disease

Frontiers in Pediatrics, 2021
Objective: This single center cross-sectional study aims to investigate the association between secondary hyperparathyroidism and body composition in pediatric patients with moderate (stage 3) and advanced (stage 4–5) chronic kidney disease (CKD).Methods:
Vasiliki Karava, Antonia Kondou, John Dotis, Athanasios Christoforidis, Anna Taparkou, Konstantina Tsioni, Evangelia Farmaki, Konstantinos Kollios, Ekaterini Siomou, Vassilios Liakopoulos, Nikoleta Printza   +10 more
doaj   +1 more source

Vitamin D Supplementation to Prevent Post‐Thyroidectomy Hypocalcemia

Clinical Endocrinology, Volume 105, Issue 2, Page 259-266, August 2026.
ABSTRACT Objective Hypocalcemia is the most common complication following thyroidectomy. Previous studies yielded inconsistent results on whether vitamin D3 prevents postoperative hypocalcemia and were conducted in non‐European countries with different dietary habits and baseline vitamin D levels.
Jeresa I. A. Willems, Daan J. L. van Twist, Kristy M. Pickwell, Patrick L. H. van Battum, Rutgert Bianchi, Annette M. Pijnenburg, James van Bastelaar, Marco Medici, Robin P. Peeters, Roderick F.A. Tummers‐de Lind van Wijngaarden   +9 more
wiley   +1 more source

Upacicalcet: A Novel Intravenous Calcimimetic Agent for Patients Undergoing Hemodialysis With Secondary Hyperparathyroidism

Therapeutic Apheresis and Dialysis, Volume 30, Issue 3, Page 309-322, June 2026.
ABSTRACT Secondary hyperparathyroidism (SHPT) is a common complication in patients receiving maintenance dialysis, driven by calcium and phosphate metabolism disturbances. Calcimimetics are central to the management of SHPT by enhancing calcium‐sensing receptor sensitivity and reducing parathyroid hormone secretion.
Fumihiko Koiwa, Daisuke Honda, Seigo Akari, Tadao Akizawa   +3 more
wiley   +1 more source

FGF23 and Immune Cell Signatures Causally Linked to Subarachnoid Hemorrhage: Evidence From Multi‐Omics and Genetic Colocalization

Brain and Behavior, Volume 16, Issue 5, May 2026.
Causal links identified between five inflammatory proteins, 22 immune cell types, and subarachnoid hemorrhage (SAH) via Mendelian randomization. Multi‐omics integration (pQTL, eQTL) revealed regulatory mechanisms underlying inflammation in SAH. FGF23 and CD4 Tregs emerged as key therapeutic targets, supported by colocalization and replication analysis.
Xingjie Shi, Cheng Zhang, Tao Yang, Zhiming Sun, Chao Wang, Lucheng Zhou, Shiqiang Hou, Ning Lin, Lanlan Zhang   +8 more
wiley   +1 more source

Common Gynecologic Issues in Patients Post‐Kidney Transplantation

Clinical Transplantation, Volume 40, Issue 5, May 2026.
ABSTRACT Advances in kidney transplantation have transformed survival and quality of life for women with end‐stage renal disease, necessitating a focus on long‐term health care for this population. Female kidney transplant recipients (KTR) experience a unique spectrum of gynecologic issues shaped by persistent hormonal dysregulation, lifelong ...
Mary Elaine Graham, Janelle Moulder, Eva Reina, Oona O'Neill, Emily McCracken   +4 more
wiley   +1 more source

Dialysate calcium, alfacalcidol, and clinical outcomes: A post-hoc analysis of the J-DAVID trial.

PLoS ONE, 2022
The selection of dialysate calcium concentration (D-Ca) is still controversial among chronic hemodialysis (HD) regimens. We examined the trajectories of CKD MBD parameters among the J-DAVID trial participants to see the effect of D-Ca and alfacalcidol ...
Kunitoshi Iseki, Daijiro Kabata, Tetsuo Shoji, Masaaki Inaba, Masanori Emoto, Katsuhito Mori, Tomoaki Morioka, Shinya Nakatani, Ayumi Shintani   +8 more
doaj   +1 more source

Endocrinologist‐Led Management of Endocrine Immune‐Related Adverse Events: Real‐World Evidence Supporting the Japan Endocrine Society Guidelines

Cancer Medicine, Volume 15, Issue 4, April 2026.
During the study period, 709 patients were treated with immune checkpoint inhibitors (ICIs) at our institution. Endocrine immune‐related adverse events (irAEs) were diagnosed in 84 patients, all of whom were evaluated and managed by endocrinologists; the most common irAEs were thyroid dysfunction (64.3%) and adrenal insufficiency (42.9%), followed by ...
Kota Nishihama, Hajime Fujimoto, Kanako Saito, Chisa Inoue, Yuko Okano, Atsuro Takeshita, Mei Uemura, Corina N. D'Alessandro‐Gabazza, Esteban C. Gabazza, Yutaka Yano, Taro Yasuma   +10 more
wiley   +1 more source

Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss

, 2005
peer reviewedIn postmenopausal osteoporosis, the administration of alfacalcidol to women resulted in an increase in trabecular bone mineral density (BMD), prevention of cortical bone loss, and a significant reduction in the incidence of further vertebral
Lecart, M. P., Reginster, Jean-Yves, Richy, F.   +2 more
core   +1 more source

Treatment of renal transplant recipients with low bone mineral density: A randomized prospective trial of alendronate, alfacalcidol, and alendronate combined with alfacalcidol

, 2008
We sought to compare the treatment modalities of alendronate, alfacalcidol, and alendronate combined with alfacalcidol in renal transplant recipients with low bone mineral density.
Trabulus, S., Serdengecti, K., Altiparmak, M. R., Sariyar, M., Apaydin, S., Trabulus, Sinan, Altiparmak, Mehmet Rıza   +6 more
core   +1 more source